Metronidazole Noridem

Metronidazole, the active ingredient in Metronidazole Noridem, is a nitroimidazole antibiotic presented as an intravenous solution for IV use. It treats a range of anaerobic bacterial and protozoal infections in adult and pediatric patients as directed by a qualified prescriber.

GNH USA supplies Metronidazole Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metronidazole is employed to manage infections caused by anaerobic bacteria and certain protozoa. - Anaerobic bacterial infections: eliminates pathogenic anaerobes in intra‑abdominal, pelvic, and soft‑tissue infections. - Bacterial vaginosis: restores normal vaginal flora by targeting Gardnerella and other anaerobes. - Trichomoniasis: eradicates Trichomonas vaginalis, relieving symptoms and preventing transmission. - Amoebiasis: treats intestinal and extra‑intestinal Entamoeba histolytica infections. - Clostridioides difficile infection: reduces toxin‑producing C. difficile, aiding clinical recovery.

Metronidazole may cause a range of adverse reactions, most of which are dose‑related and reversible upon discontinuation.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient metallic sensation in the mouth. - Headache: occasional dull or throbbing pain. - Diarrhea: loose stools that resolve after therapy. - Dark urine: harmless discoloration of urine.

Serious or Rare Side Effects: - Peripheral neuropathy: tingling or numbness in extremities. - Seizures: rare convulsive episodes. - Stevens‑Johnson syndrome: severe skin and mucous membrane reaction. - Hepatotoxicity: elevated liver enzymes or jaundice. - Hypersensitivity: rash, fever, or anaphylaxis.

Before initiating therapy, clinicians should consider patient‑specific factors and monitor for potential complications. - Renal impairment: adjust dosing or monitor serum levels in severe dysfunction. - Hepatic disease: use with caution; monitor liver function tests. - Alcohol consumption: advise avoidance of alcohol due to disulfiram‑like reaction. - Pregnancy and lactation: evaluate risk‑benefit ratio; limited safety data available. - Concomitant neurotoxic drugs: avoid or monitor for additive neuropathy. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Metronidazole can alter the activity of several co‑administered medicines, requiring careful management.

Major Interactions (Avoid): - Disulfiram: may cause severe flushing, tachycardia, and hypotension. - Warfarin: potentiates anticoagulant effect, increasing bleeding risk. - Lithium: can raise serum lithium levels, leading to toxicity.

Moderate Interactions (Monitor Closely): - Phenytoin: may reduce phenytoin concentrations. - Cimetidine: can increase metronidazole plasma levels. - Alcohol: concurrent use may precipitate a disulfiram‑like reaction.